Podcast Episodes
Back to Search
What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma
Season 1
Professor Philippe Moreau from the University Hospital of Nantes in France discusses anti-CD38 antibody-based treatment approaches for newly…
2 years, 11 months ago
Practical Perspectives: Investigators Discuss Current Management and Actual Cases of Relapsed/Refractory Metastatic Colorectal Cancer
Season 1
Dr Kristen K Ciombor from the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, and Dr J Randolph Hecht from UCLA’s David Geffen Scho…
2 years, 11 months ago
Blastic Plasmacytoid Dendritic Cell Neoplasm
Season 1
Dr Naveen Pemmaraju from the University of Texas MD Anderson Cancer Center in Houston, Texas, discusses current and emerging management appr…
2 years, 11 months ago
Inside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer
Season 1
Dr Hope Rugo from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, and Dr Tiffany Traina from Memorial…
2 years, 11 months ago
Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma
Season 1
Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston discusses the emerging role of CELMoDs and other novel approaches to target…
2 years, 11 months ago
Novel Agents and Strategies in the Treatment of Ovarian Cancer
Season 1
Dr Debra L Richardson from OU Health Stephenson Cancer Center in Oklahoma City discusses novel agents and strategies for ovarian cancer mode…
2 years, 11 months ago
What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors
Season 1
Dr Nicole Lamanna from the Columbia University Herbert Irving Comprehensive Cancer Center in New York, New York, and Dr William G Wierda fro…
3 years ago
Optimizing the Management of Metastatic Pancreatic Cancer
Season 1
Dr Eileen M O’Reilly from Memorial Sloan Kettering Cancer Center in New York City and Dr Zev A Wainberg from the UCLA Jonsson Comprehensive …
3 years ago
The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
Season 1
Dr Martin Hutchings from Rigshospitalet, Copenhagen University Hospital in Copenhagen, Denmark, and Dr Loretta Nastoupil from The University…
3 years ago
Meet The Professor: Optimizing the Management of Melanoma
Season 1
Prof Georgina Long from the University of Sydney in Sydney, New South Wales, Australia, discusses optimizing the management of melanoma mode…
3 years ago